Health stocks: pent up demand returning in time

Nedbank Private Wealth’s Preston Narainsamy on Life Healthcare’s Alzheimer’s drug and Q1 GDP figures. Sygnia CEO David Hufton unpacks results as passive investing continues to grow. Omri Thomas, director of Abax Investments, talks mandate drift and equities for income.

AUTHOR PROFILE

COMMENTS   0

You must be signed in and an Insider Gold subscriber to comment.

SUBSCRIBE NOW SIGN IN

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD

Instrument Details  

You do not have any portfolios, please create one here.
You do not have an alert portfolio, please create one here.
INSIDER SUBSCRIPTION APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING

Follow us:

Search Articles:
Click a Company: